Skip to main content
. 2020 Feb 15;46(4):795–803. doi: 10.1093/schbul/sbz126

Table 1.

Demographic Data and Incidence of Any STI Among Adolescents and Young Adults With Schizophrenia and Controls

Demographics Schizophrenia (n = 44 109) Controls (n = 176 436) P value
Age at enrollment (years, SD, n, %) 23.28 (4.38) 23.29 (4.39) .805
Male: female (%) 58.2%: 41.8% 58.2%: 41.8% 1.000
Atypical antipsychotics (n, %) <.001
 <30 cDDD 10 268 (23.3) 175 866 (99.7)
 30–364 cDDD 9518 (21.6) 464 (0.3)
 ≥365 cDDD 24 323 (55.1) 106 (0.1)
Frequency of admission for schizophrenia (n, %)
 <1/year 38 972 (88.4)
 1–2/year 2706 (6.1)
 >2/year 2431 (5.5)
Incidence of any STI (n, 100,000 person-years) 1306 (363.40) 2216 (152.10) <.001
 HIV 119 (32.59) 133 (9.09) <.001
 Syphilis 266 (73.05) 181 (12.38) <.001
 Genital warts 250 (68.52) 406 (27.77) <.001
 Gonorrhea 145 (39.73) 189 (12.92) <.001
 Chlamydial infection 188 (51.50) 483 (33.04) <.001
 Trichomoniasis 456 (125.44) 912 (62.45) <.001
Age at any STI (years, SD) 27.41 (4.96) 31.57 (4.26) <.001
Time to first STI (years, SD) 3.97 (2.80) 6.33 (2.58) <.001
Psychiatric comorbidities (n, %)
 Disruptive behavior disorders 1002 (2.3) 219 (0.1) <.001
 Alcohol use disorders 3244 (7.4) 3561 (2.0) <.001
 Substance use disorders 6205 (14.1) 5089 (2.9) <.001
 IV drug abuse/dependence 191 (0.4) 107 (0.1) <.001
Level of urbanization <.001
 1 (most urbanized) 8877 (20.1) 56 535 (32.0)
 2 14 055 (31.9) 55 371 (31.4)
 3 6531 (14.8) 33 262 (18.9)
 4 5550 (12.6) 20 888 (11.8)
 5 (most rural) 9096 (20.6) 10 380 (5.9)
Income-related insured amount <.001
 ≤15 840 NTD/month 27 447 (62.2) 48 674 (27.6)
 15 841–25 000 NTD/month 13 701 (31.1) 66 244 (37.5)
 ≥25 001 NTD/month 2961 (6.7) 61 518 (34.9)
Follow-up duration (years) 8.15 (2.81) 8.26 (2.71) <.001

Note: STI, sexually transmitted infection; NTD, new Taiwan dollar; SD, standard deviation; IV, intravenous; cDDD, cumulative defined daily dose.